"What we're left with is
the health plans and the government agencies doing their best to keep up with
these things as they come out and evaluating the evidence and making
recommendations on them. That leads to some variation in opinions on whether
tests should be paid for or not."
— Lon Castle, M.D., chief of molecular diagnostics and specialty
drug management at eviCore healthcare, spoke with AIS's Health Plan Weekly about
the variance in coverage of genetic testing across the spectrum of types of
health insurance.
No comments:
Post a Comment